Content overview: “Fitbit Adds Insulin Resistance and Blood Pressure Trends to New Devices, Advancing Non-Inv”. Fitbit is rolling out new health features on two of its latest devices that track insulin resistance and blood pressure trends, marking a significant step toward non-invasive glucose monitoring. The features appear on the Fitbit Sense 2 and Fitbit Versa 4, according to the source. Fitbit Adds Insulin Resistance and Blood Pressure Trends to New Devices, Advancing Non-Invasive Glucose Tracking
Insulin resistance tracking uses heart rate, activity, and sleep data to estimate how the body responds to insulin, while blood pressure trends are derived from pulse arrival time. These additions could help millions of users monitor metabolic health without needles or cuffs. The move positions Fitbit, owned by Google, in a growing market for wearable health tech that competes with Apple and Samsung. The full version stays on the original page, which this listing opens directly.